Furthermore, a number of studies have suggested that NRG1 administration can ameliorate cognitive impairments in cerebral ischemia and neurodegenerative diseases (Rong et al., 2015; Ryu et al., 2016). The gene discussed is NRG1; the disease is brain ischemia.